In 1932 Giuseppe Caraccia founded L.I.M. (Laboratorio Italiano Medicinali), which later became Bioindustria Farmaceutici Spa and today Bioindustria L.I.M. SpA.
With almost 100 years of experience, Bioindustria L.I.M. currently represents a reference point at national and international level, both for the specialization of its production and for the modernity of its research laboratories and industrial plants.
Bioindustria L.I.M. markets its finished products and APIs in much of the world and the international share of its turnover is constantly growing thanks to numerous strategic alliances signed with important global pharmaceutical groups.
According to the regulatory changes introduced by Legislative Decree no. 24 of 10 March 2023, Bioindustria LIM S.p.A. has adopted the necessary system for reporting ("internal reporting").